Report Cover

Global Travelers Vaccines Market Insights and Forecast to 2027


Travelers Vaccines market is segmented by Type, and by End Users. Players, stakeholders, and other participants in the global Travelers Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by End Users for the period 2016-2027.

Segment by Type
    Meningococcal Vaccine
    Japanese Encephalitis Vaccine
    Yellow Fever Vaccine
    Hepatitis Vaccine
    Cholera Vaccine
    Other

Segment by End Users
    Tourists
    Students
    Workers
    Others

By Company
    GlaxoSmithKline
    Sanofi Pasteur
    Merck
    Pfizer
    CNBG
    Sanofi Pasteur MSD
    Serum Institute of India
    Biokangtai

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
1 Study Coverage
    1.1 Travelers Vaccines Product Introduction
    1.2 Market by Type
        1.2.1 Global Travelers Vaccines Market Size Growth Rate by Type
        1.4.2 Meningococcal Vaccine
        1.4.3 Japanese Encephalitis Vaccine
        1.2.4 Yellow Fever Vaccine
        1.2.5 Hepatitis Vaccine
        1.2.6 Cholera Vaccine
        1.2.7 Other
    1.3 Market by End Users
        1.3.1 Global Travelers Vaccines Market Size Growth Rate by End Users
        1.3.2 Tourists
        1.3.3 Students
        1.3.4 Workers
        1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
    2.1 Global Travelers Vaccines Sales Estimates and Forecasts 2016-2027
    2.2 Global Travelers Vaccines Revenue Estimates and Forecasts 2016-2027
    2.3 Global Travelers Vaccines Revenue by Region: 2016 VS 2021 VS 2027
    2.4 Global Top Travelers Vaccines Regions by Sales
        2.4.1 Global Top Travelers Vaccines Regions by Sales (2016-2021)
        2.4.2 Global Top Travelers Vaccines Regions by Sales (2022-2027)
    2.5 Global Top Travelers Vaccines Regions by Revenue
        2.5.1 Global Top Travelers Vaccines Regions by Revenue (2016-2021)
        2.5.2 Global Top Travelers Vaccines Regions by Revenue (2022-2027)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Travelers Vaccines Sales by Manufacturers
        3.1.1 Global Top Travelers Vaccines Manufacturers by Sales (2016-2021)
        3.1.2 Global Top Travelers Vaccines Manufacturers Market Share by Sales (2016-2021)
        3.1.3 Global Top 10 and Top 5 Companies by Travelers Vaccines Sales in 2020
    3.2 Global Travelers Vaccines Revenue by Manufacturers
        3.2.1 Global Top Travelers Vaccines Manufacturers by Revenue (2016-2021)
        3.2.2 Global Top Travelers Vaccines Manufacturers Market Share by Revenue (2016-2021)
        3.2.3 Global Top 10 and Top 5 Companies by Travelers Vaccines Revenue in 2020
    3.3 Global Travelers Vaccines Sales Price by Manufacturers
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Travelers Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Travelers Vaccines Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
    4.1 Global Travelers Vaccines Sales by Type
        4.1.1 Global Travelers Vaccines Historical Sales by Type (2016-2021)
        4.1.2 Global Travelers Vaccines Forecasted Sales by Type (2022-2027)
        4.1.3 Global Travelers Vaccines Sales Market Share by Type (2016-2027)
    4.2 Global Travelers Vaccines Revenue by Type
        4.2.1 Global Travelers Vaccines Historical Revenue by Type (2016-2021)
        4.2.2 Global Travelers Vaccines Forecasted Revenue by Type (2022-2027)
        4.2.3 Global Travelers Vaccines Revenue Market Share by Type (2016-2027)
    4.3 Global Travelers Vaccines Price by Type
        4.3.1 Global Travelers Vaccines Price by Type (2016-2021)
        4.3.2 Global Travelers Vaccines Price Forecast by Type (2022-2027)
5 Market Size by Application
    5.1 Global Travelers Vaccines Sales by End Users
        5.1.1 Global Travelers Vaccines Historical Sales by End Users (2016-2021)
        5.1.2 Global Travelers Vaccines Forecasted Sales by End Users (2022-2027)
        5.1.3 Global Travelers Vaccines Sales Market Share by End Users (2016-2027)
    5.2 Global Travelers Vaccines Revenue by End Users
        5.2.1 Global Travelers Vaccines Historical Revenue by End Users (2016-2021)
        5.2.2 Global Travelers Vaccines Forecasted Revenue by End Users (2022-2027)
        5.2.3 Global Travelers Vaccines Revenue Market Share by End Users (2016-2027)
    5.3 Global Travelers Vaccines Price by End Users
        5.3.1 Global Travelers Vaccines Price by End Users (2016-2021)
        5.3.2 Global Travelers Vaccines Price Forecast by End Users (2022-2027)

6 North America
    6.1 North America Travelers Vaccines Market Size by Type
        6.1.1 North America Travelers Vaccines Sales by Type (2016-2027)
        6.1.2 North America Travelers Vaccines Revenue by Type (2016-2027)
    6.2 North America Travelers Vaccines Market Size by End Users
        6.2.1 North America Travelers Vaccines Sales by End Users (2016-2027)
        6.2.2 North America Travelers Vaccines Revenue by End Users (2016-2027)
    6.3 North America Travelers Vaccines Market Size by Country
        6.3.1 North America Travelers Vaccines Sales by Country (2016-2027)
        6.3.2 North America Travelers Vaccines Revenue by Country (2016-2027)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Travelers Vaccines Market Size by Type
        7.1.1 Europe Travelers Vaccines Sales by Type (2017-2027)
        7.1.2 Europe Travelers Vaccines Revenue by Type (2017-2027)
    7.2 Europe Travelers Vaccines Market Size by End Users
        7.2.1 Europe Travelers Vaccines Sales by End Users (2017-2027)
        7.2.2 Europe Travelers Vaccines Revenue by End Users (2017-2027)
    7.3 Europe Travelers Vaccines Market Size by Country
        7.3.1 Europe Travelers Vaccines Sales by Country (2017-2027)
        7.3.2 Europe Travelers Vaccines Revenue by Country (2017-2027)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Travelers Vaccines Market Size by Type
        8.1.1 Asia Pacific Travelers Vaccines Sales by Type (2018-2027)
        8.1.2 Asia Pacific Travelers Vaccines Revenue by Type (2018-2027)
    8.2 Asia Pacific Travelers Vaccines Market Size by End Users
        8.2.1 Asia Pacific Travelers Vaccines Sales by End Users (2018-2027)
        8.2.2 Asia Pacific Travelers Vaccines Revenue by End Users (2018-2027)
    8.3 Asia Pacific Travelers Vaccines Market Size by Region
        8.3.1 Asia Pacific Travelers Vaccines Sales by Region (2018-2027)
        8.3.2 Asia Pacific Travelers Vaccines Revenue by Region (2018-2027)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Travelers Vaccines Market Size by Type
        9.1.1 Latin America Travelers Vaccines Sales by Type (2019-2027)
        9.1.2 Latin America Travelers Vaccines Revenue by Type (2019-2027)
    9.2 Latin America Travelers Vaccines Market Size by End Users
        9.2.1 Latin America Travelers Vaccines Sales by End Users (2019-2027)
        9.2.2 Latin America Travelers Vaccines Revenue by End Users (2019-2027)
    9.3 Latin America Travelers Vaccines Market Size by Country
        9.3.1 Latin America Travelers Vaccines Sales by Country (2019-2027)
        9.3.2 Latin America Travelers Vaccines Revenue by Country (2019-2027)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
6 Middle East and Africa
    6.1 Middle East and Africa Travelers Vaccines Market Size by Type
        6.1.1 Middle East and Africa Travelers Vaccines Sales by Type (2016-2027)
        6.1.2 Middle East and Africa Travelers Vaccines Revenue by Type (2016-2027)
    6.2 Middle East and Africa Travelers Vaccines Market Size by End Users
        6.2.1 Middle East and Africa Travelers Vaccines Sales by End Users (2016-2027)
        6.2.2 Middle East and Africa Travelers Vaccines Revenue by End Users (2016-2027)
    6.3 Middle East and Africa Travelers Vaccines Market Size by Country
        6.3.1 Middle East and Africa Travelers Vaccines Sales by Country (2016-2027)
        6.3.2 Middle East and Africa Travelers Vaccines Revenue by Country (2016-2027)
        6.3.3 Turkey
        6.3.4 Saudi Arabia
        6.3.5 U.A.E

11 Company Profiles
    11.1 GlaxoSmithKline
        11.1.1 GlaxoSmithKline Corporation Information
        11.1.2 GlaxoSmithKline Overview
        11.1.3 GlaxoSmithKline Travelers Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
        11.1.4 GlaxoSmithKline Travelers Vaccines Product Description
        11.1.5 GlaxoSmithKline Related Developments
    11.2 Sanofi Pasteur
        11.2.1 Sanofi Pasteur Corporation Information
        11.2.2 Sanofi Pasteur Overview
        11.2.3 Sanofi Pasteur Travelers Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
        11.2.4 Sanofi Pasteur Travelers Vaccines Product Description
        11.2.5 Sanofi Pasteur Related Developments
    11.3 Merck
        11.3.1 Merck Corporation Information
        11.3.2 Merck Overview
        11.3.3 Merck Travelers Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
        11.3.4 Merck Travelers Vaccines Product Description
        11.3.5 Merck Related Developments
    11.4 Pfizer
        11.4.1 Pfizer Corporation Information
        11.4.2 Pfizer Overview
        11.4.3 Pfizer Travelers Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
        11.4.4 Pfizer Travelers Vaccines Product Description
        11.4.5 Pfizer Related Developments
    11.5 CNBG
        11.5.1 CNBG Corporation Information
        11.5.2 CNBG Overview
        11.5.3 CNBG Travelers Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
        11.5.4 CNBG Travelers Vaccines Product Description
        11.5.5 CNBG Related Developments
    11.6 Sanofi Pasteur MSD
        11.6.1 Sanofi Pasteur MSD Corporation Information
        11.6.2 Sanofi Pasteur MSD Overview
        11.6.3 Sanofi Pasteur MSD Travelers Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
        11.6.4 Sanofi Pasteur MSD Travelers Vaccines Product Description
        11.6.5 Sanofi Pasteur MSD Related Developments
    11.7 Serum Institute of India
        11.7.1 Serum Institute of India Corporation Information
        11.7.2 Serum Institute of India Overview
        11.7.3 Serum Institute of India Travelers Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
        11.7.4 Serum Institute of India Travelers Vaccines Product Description
        11.7.5 Serum Institute of India Related Developments
    11.8 Biokangtai
        11.8.1 Biokangtai Corporation Information
        11.8.2 Biokangtai Overview
        11.8.3 Biokangtai Travelers Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
        11.8.4 Biokangtai Travelers Vaccines Product Description
        11.8.5 Biokangtai Related Developments
    11.1 GlaxoSmithKline
        11.1.1 GlaxoSmithKline Corporation Information
        11.1.2 GlaxoSmithKline Overview
        11.1.3 GlaxoSmithKline Travelers Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
        11.1.4 GlaxoSmithKline Travelers Vaccines Product Description
        11.1.5 GlaxoSmithKline Related Developments

12 Value Chain and Sales Channels Analysis
    12.1 Travelers Vaccines Value Chain Analysis
    12.2 Travelers Vaccines Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Travelers Vaccines Production Mode & Process
    12.4 Travelers Vaccines Sales and Marketing
        12.4.1 Travelers Vaccines Sales Channels
        12.4.2 Travelers Vaccines Distributors
    12.5 Travelers Vaccines Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Travelers Vaccines Industry Trends
    13.2 Travelers Vaccines Market Drivers
    13.3 Travelers Vaccines Market Challenges
    13.4 Travelers Vaccines Market Restraints

14 Key Findings in The Global Travelers Vaccines Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables Table 1. Global Travelers Vaccines Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Meningococcal Vaccine Table 3. Major Manufacturers of Japanese Encephalitis Vaccine Table 4. Major Manufacturers of Yellow Fever Vaccine Table 5. Major Manufacturers of Hepatitis Vaccine Table 6. Major Manufacturers of Cholera Vaccine Table 7. Major Manufacturers of Other Table 8. Global Travelers Vaccines Market Size Growth Rate by End Users, 2016 VS 2021 VS 2027 (US$ Million) Table 9. Global Travelers Vaccines Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million) Table 10. Global Travelers Vaccines Sales by Region (2016-2021) & (K Doses) Table 11. Global Travelers Vaccines Sales Market Share by Region (2016-2021) Table 12. Global Travelers Vaccines Sales by Region (2016-2021) & (K Doses) Table 13. Global Travelers Vaccines Sales Market Share by Region (2022-2027) Table 14. Global Travelers Vaccines Revenue by Region (2016-2021) & (US$ Million) Table 15. Global Travelers Vaccines Revenue Market Share by Region (2016-2021) Table 16. Global Travelers Vaccines Revenue by Region (2022-2027) & (US$ Million) Table 17. Global Travelers Vaccines Revenue Market Share by Region (2022-2027) Table 18. Global Travelers Vaccines Sales by Manufacturers (2016-2021) & (K Doses) Table 19. Global Travelers Vaccines Sales Share by Manufacturers (2016-2021) Table 20. Global Travelers Vaccines Revenue by Manufacturers (2016-2021) & (US$ Million) Table 21. Global Travelers Vaccines Revenue Share by Manufacturers (2016-2021) Table 22. Travelers Vaccines Price by Manufacturers 2016-2021 (USD/Dose) Table 23. Global Travelers Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) Table 24. Global Travelers Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Travelers Vaccines as of 2020) Table 25. Travelers Vaccines Manufacturing Base Distribution and Headquarters Table 26. Manufacturers Travelers Vaccines Product Offered Table 27. Date of Manufacturers Enter into Travelers Vaccines Market Table 28. Mergers & Acquisitions, Expansion Plans Table 29. Global Travelers Vaccines Sales by Type (2016-2021) & (K Doses) Table 30. Global Travelers Vaccines Sales by Type (2022-2027) & (K Doses) Table 31. Global Travelers Vaccines Sales Share by Type (2016-2021) Table 32. Global Travelers Vaccines Sales Share by Type (2022-2027) Table 33. Global Travelers Vaccines Revenue by Type (2016-2021) & (US$ Million) Table 34. Global Travelers Vaccines Revenue by Type (2022-2027) & (US$ Million) Table 35. Global Travelers Vaccines Revenue Share by Type (2016-2021) Table 36. Global Travelers Vaccines Revenue Share by Type (2022-2027) Table 37. Travelers Vaccines Price by Type (2016-2021) & (USD/Dose) Table 38. Global Travelers Vaccines Price Forecast by Type (2022-2027) & (USD/Dose) Table 39. Global Travelers Vaccines Sales by End Users (2016-2021) & (K Doses) Table 40. Global Travelers Vaccines Sales by End Users (2022-2027) & (K Doses) Table 41. Global Travelers Vaccines Sales Share by End Users (2016-2021) Table 42. Global Travelers Vaccines Sales Share by End Users (2022-2027) Table 43. Global Travelers Vaccines Revenue by End Users (2016-2021) & (US$ Million) Table 44. Global Travelers Vaccines Revenue by End Users (2022-2027) & (US$ Million) Table 45. Global Travelers Vaccines Revenue Share by End Users (2016-2021) Table 46. Global Travelers Vaccines Revenue Share by End Users (2022-2027) Table 47. Travelers Vaccines Price by End Users (2016-2021) & (USD/Dose) Table 48. Global Travelers Vaccines Price Forecast by End Users (2022-2027) & (USD/Dose) Table 49. North America Travelers Vaccines Sales by Type (2016-2021) & (K Doses) Table 50. North America Travelers Vaccines Sales by Type (2022-2027) & (K Doses) Table 51. North America Travelers Vaccines Revenue by Type (2016-2021) & (US$ Million) Table 52. North America Travelers Vaccines Revenue by Type (2022-2027) & (US$ Million) Table 53. North America Travelers Vaccines Sales by End Users (2016-2021) & (K Doses) Table 54. North America Travelers Vaccines Sales by End Users (2022-2027) & (K Doses) Table 55. North America Travelers Vaccines Revenue by End Users (2016-2021) & (US$ Million) Table 56. North America Travelers Vaccines Revenue by End Users (2022-2027) & (US$ Million) Table 57. North America Travelers Vaccines Sales by Country (2016-2021) & (K Doses) Table 58. North America Travelers Vaccines Sales by Country (2022-2027) & (K Doses) Table 59. North America Travelers Vaccines Revenue by Country (2016-2021) & (US$ Million) Table 60. North America Travelers Vaccines Revenue by Country (2022-2027) & (US$ Million) Table 61. Europe Travelers Vaccines Sales by Type (2016-2021) & (K Doses) Table 62. Europe Travelers Vaccines Sales by Type (2022-2027) & (K Doses) Table 63. Europe Travelers Vaccines Revenue by Type (2016-2021) & (US$ Million) Table 64. Europe Travelers Vaccines Revenue by Type (2022-2027) & (US$ Million) Table 65. Europe Travelers Vaccines Sales by End Users (2016-2021) & (K Doses) Table 66. Europe Travelers Vaccines Sales by End Users (2022-2027) & (K Doses) Table 67. Europe Travelers Vaccines Revenue by End Users (2016-2021) & (US$ Million) Table 68. Europe Travelers Vaccines Revenue by End Users (2022-2027) & (US$ Million) Table 69. Europe Travelers Vaccines Sales by Country (2016-2021) & (K Doses) Table 70. Europe Travelers Vaccines Sales by Country (2022-2027) & (K Doses) Table 71. Europe Travelers Vaccines Revenue by Country (2016-2021) & (US$ Million) Table 72. Europe Travelers Vaccines Revenue by Country (2022-2027) & (US$ Million) Table 73. Asia Pacific Travelers Vaccines Sales by Type (2016-2021) & (K Doses) Table 74. Asia Pacific Travelers Vaccines Sales by Type (2022-2027) & (K Doses) Table 75. Asia Pacific Travelers Vaccines Revenue by Type (2016-2021) & (US$ Million) Table 76. Asia Pacific Travelers Vaccines Revenue by Type (2022-2027) & (US$ Million) Table 77. Asia Pacific Travelers Vaccines Sales by End Users (2016-2021) & (K Doses) Table 78. Asia Pacific Travelers Vaccines Sales by End Users (2022-2027) & (K Doses) Table 79. Asia Pacific Travelers Vaccines Revenue by End Users (2016-2021) & (US$ Million) Table 80. Asia Pacific Travelers Vaccines Revenue by End Users (2022-2027) & (US$ Million) Table 81. Asia Pacific Travelers Vaccines Sales by Region (2016-2021) & (K Doses) Table 82. Asia Pacific Travelers Vaccines Sales by Region (2022-2027) & (K Doses) Table 83. Asia Pacific Travelers Vaccines Revenue by Region (2016-2021) & (US$ Million) Table 84. Asia Pacific Travelers Vaccines Revenue by Region (2022-2027) & (US$ Million) Table 85. Latin America Travelers Vaccines Sales by Type (2016-2021) & (K Doses) Table 86. Latin America Travelers Vaccines Sales by Type (2022-2027) & (K Doses) Table 87. Latin America Travelers Vaccines Revenue by Type (2016-2021) & (US$ Million) Table 88. Latin America Travelers Vaccines Revenue by Type (2022-2027) & (US$ Million) Table 89. Latin America Travelers Vaccines Sales by End Users (2016-2021) & (K Doses) Table 90. Latin America Travelers Vaccines Sales by End Users (2022-2027) & (K Doses) Table 91. Latin America Travelers Vaccines Revenue by End Users (2016-2021) & (US$ Million) Table 92. Latin America Travelers Vaccines Revenue by End Users (2022-2027) & (US$ Million) Table 93. Latin America Travelers Vaccines Sales by Country (2016-2021) & (K Doses) Table 94. Latin America Travelers Vaccines Sales by Country (2022-2027) & (K Doses) Table 95. Latin America Travelers Vaccines Revenue by Country (2016-2021) & (US$ Million) Table 96. Latin America Travelers Vaccines Revenue by Country (2022-2027) & (US$ Million) Table 97. Middle East and Africa Travelers Vaccines Sales by Type (2016-2021) & (K Doses) Table 98. Middle East and Africa Travelers Vaccines Sales by Type (2022-2027) & (K Doses) Table 99. Middle East and Africa Travelers Vaccines Revenue by Type (2016-2021) & (US$ Million) Table 100. Middle East and Africa Travelers Vaccines Revenue by Type (2022-2027) & (US$ Million) Table 101. Middle East and Africa Travelers Vaccines Sales by End Users (2016-2021) & (K Doses) Table 102. Middle East and Africa Travelers Vaccines Sales by End Users (2022-2027) & (K Doses) Table 103. Middle East and Africa Travelers Vaccines Revenue by End Users (2016-2021) & (US$ Million) Table 104. Middle East and Africa Travelers Vaccines Revenue by End Users (2022-2027) & (US$ Million) Table 105. Middle East and Africa Travelers Vaccines Sales by Country (2016-2021) & (K Doses) Table 106. Middle East and Africa Travelers Vaccines Sales by Country (2022-2027) & (K Doses) Table 107. Middle East and Africa Travelers Vaccines Revenue by Country (2016-2021) & (US$ Million) Table 108. Middle East and Africa Travelers Vaccines Revenue by Country (2022-2027) & (US$ Million) Table 109. GlaxoSmithKline Corporation Information Table 110. GlaxoSmithKline Description and Major Businesses Table 111. GlaxoSmithKline Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 112. GlaxoSmithKline Travelers Vaccines Product Table 113. GlaxoSmithKline Recent Developments Table 114. Sanofi Pasteur Corporation Information Table 115. Sanofi Pasteur Description and Major Businesses Table 116. Sanofi Pasteur Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 117. Sanofi Pasteur Travelers Vaccines Product Table 118. Sanofi Pasteur Recent Developments Table 119. Merck Corporation Information Table 120. Merck Description and Major Businesses Table 121. Merck Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 122. Merck Travelers Vaccines Product Table 123. Merck Recent Developments Table 124. Pfizer Corporation Information Table 125. Pfizer Description and Major Businesses Table 126. Pfizer Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 127. Pfizer Travelers Vaccines Product Table 128. Pfizer Recent Developments Table 129. CNBG Corporation Information Table 130. CNBG Description and Major Businesses Table 131. CNBG Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 132. CNBG Travelers Vaccines Product Table 133. CNBG Recent Developments Table 134. Sanofi Pasteur MSD Corporation Information Table 135. Sanofi Pasteur MSD Description and Major Businesses Table 136. Sanofi Pasteur MSD Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 137. Sanofi Pasteur MSD Travelers Vaccines Product Table 138. Sanofi Pasteur MSD Recent Developments Table 139. Serum Institute of India Corporation Information Table 140. Serum Institute of India Description and Major Businesses Table 141. Serum Institute of India Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 142. Serum Institute of India Travelers Vaccines Product Table 143. Serum Institute of India Recent Developments Table 144. Biokangtai Corporation Information Table 145. Biokangtai Description and Major Businesses Table 146. Biokangtai Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 147. Biokangtai Travelers Vaccines Product Table 148. Biokangtai Recent Developments Table 149. Key Raw Materials Lists Table 150. Raw Materials Key Suppliers Lists Table 151. Travelers Vaccines Distributors List Table 152. Travelers Vaccines Customers List Table 153. Travelers Vaccines Market Trends Table 154. Travelers Vaccines Market Drivers Table 155. Travelers Vaccines Market Challenges Table 156. Travelers Vaccines Market Restraints Table 157. Research Programs/Design for This Report Table 158. Key Data Information from Secondary Sources Table 159. Key Data Information from Primary Sources List of Figures Figure 1. Travelers Vaccines Product Picture Figure 2. Global Travelers Vaccines Market Share by Type in 2020 & 2027 Figure 3. Meningococcal Vaccine Product Picture Figure 4. Japanese Encephalitis Vaccine Product Picture Figure 5. Yellow Fever Vaccine Product Picture Figure 6. Hepatitis Vaccine Product Picture Figure 7. Cholera Vaccine Product Picture Figure 8. Other Product Picture Figure 9. Global Travelers Vaccines Sales Market Share by End Users in 2020 & 2027 Figure 10. Tourists Figure 11. Students Figure 12. Workers Figure 13. Others Figure 14. Travelers Vaccines Report Years Considered Figure 15. Global Travelers Vaccines Sales 2016-2027 (K Doses) Figure 16. Global Travelers Vaccines Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 17. Global Travelers Vaccines Revenue 2016-2027 (US$ Million) Figure 18. Global Travelers Vaccines Revenue Market Share by Region in Percentage: 2020 Versus 2027 Figure 19. Global Travelers Vaccines Sales Market Share by Region (2016-2021) Figure 20. Global Travelers Vaccines Sales Market Share by Region (2022-2027) Figure 21. North America Travelers Vaccines Sales YoY (2016-2027) & (K Doses) Figure 22. North America Travelers Vaccines Revenue YoY (2016-2027) & (US$ Million) Figure 23. Europe Travelers Vaccines Sales YoY (2016-2027) & (K Doses) Figure 24. Europe Travelers Vaccines Revenue YoY (2016-2027) & (US$ Million) Figure 25. Asia-Pacific Travelers Vaccines Sales YoY (2016-2027) & (K Doses) Figure 26. Asia-Pacific Travelers Vaccines Revenue YoY (2016-2027) & (US$ Million) Figure 27. Latin America Travelers Vaccines Sales YoY (2016-2027) & (K Doses) Figure 28. Latin America Travelers Vaccines Revenue YoY (2016-2027) & (US$ Million) Figure 29. Middle East & Africa Travelers Vaccines Sales YoY (2016-2027) & (K Doses) Figure 30. Middle East & Africa Travelers Vaccines Revenue YoY (2016-2027) & (US$ Million) Figure 31. The Top 10 and Top 5 Players Market Share by Travelers Vaccines Sales in 2020 Figure 32. The Top 10 and Top 5 Players Market Share by Travelers Vaccines Revenue in 2020 Figure 33. Travelers Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 34. Global Travelers Vaccines Sales Market Share by Type (2016-2027) Figure 35. Global Travelers Vaccines Revenue Market Share by Type (2016-2027) Figure 36. Global Travelers Vaccines Sales Market Share by End Users (2016-2027) Figure 37. Global Travelers Vaccines Revenue Market Share by End Users (2016-2027) Figure 38. North America Travelers Vaccines Sales Market Share by Type (2016-2027) Figure 39. North America Travelers Vaccines Revenue Market Share by Type (2016-2027) Figure 40. North America Travelers Vaccines Sales Market Share by End Users (2016-2027) Figure 41. North America Travelers Vaccines Revenue Market Share by End Users (2016-2027) Figure 42. North America Travelers Vaccines Sales Share by Country (2016-2027) Figure 43. North America Travelers Vaccines Revenue Share by Country (2016-2027) Figure 44. U.S. Travelers Vaccines Revenue (2016-2027) & (US$ Million) Figure 45. Canada Travelers Vaccines Revenue (2016-2027) & (US$ Million) Figure 46. Europe Travelers Vaccines Sales Market Share by Type (2016-2027) Figure 47. Europe Travelers Vaccines Revenue Market Share by Type (2016-2027) Figure 48. Europe Travelers Vaccines Sales Market Share by End Users (2016-2027) Figure 49. Europe Travelers Vaccines Revenue Market Share by End Users (2016-2027) Figure 50. Europe Travelers Vaccines Sales Share by Country (2016-2027) Figure 51. Europe Travelers Vaccines Revenue Share by Country (2016-2027) Figure 52. Germany Travelers Vaccines Revenue (2016-2027) & (US$ Million) Figure 53. France Travelers Vaccines Revenue (2016-2027) & (US$ Million) Figure 54. U.K. Travelers Vaccines Revenue (2016-2027) & (US$ Million) Figure 55. Italy Travelers Vaccines Revenue (2016-2027) & (US$ Million) Figure 56. Russia Travelers Vaccines Revenue (2016-2027) & (US$ Million) Figure 57. Asia Pacific Travelers Vaccines Sales Market Share by Type (2016-2027) Figure 58. Asia Pacific Travelers Vaccines Revenue Market Share by Type (2016-2027) Figure 59. Asia Pacific Travelers Vaccines Sales Market Share by End Users (2016-2027) Figure 60. Asia Pacific Travelers Vaccines Revenue Market Share by End Users (2016-2027) Figure 61. Asia Pacific Travelers Vaccines Sales Share by Region (2016-2027) Figure 62. Asia Pacific Travelers Vaccines Revenue Share by Region (2016-2027) Figure 63. China Travelers Vaccines Revenue (2016-2027) & (US$ Million) Figure 64. Japan Travelers Vaccines Revenue (2016-2027) & (US$ Million) Figure 65. South Korea Travelers Vaccines Revenue (2016-2027) & (US$ Million) Figure 66. India Travelers Vaccines Revenue (2016-2027) & (US$ Million) Figure 67. Australia Travelers Vaccines Revenue (2016-2027) & (US$ Million) Figure 68. Taiwan Travelers Vaccines Revenue (2016-2027) & (US$ Million) Figure 69. Indonesia Travelers Vaccines Revenue (2016-2027) & (US$ Million) Figure 70. Thailand Travelers Vaccines Revenue (2016-2027) & (US$ Million) Figure 71. Malaysia Travelers Vaccines Revenue (2016-2027) & (US$ Million) Figure 72. Philippines Travelers Vaccines Revenue (2016-2027) & (US$ Million) Figure 73. Latin America Travelers Vaccines Sales Market Share by Type (2016-2027) Figure 74. Latin America Travelers Vaccines Revenue Market Share by Type (2016-2027) Figure 75. Latin America Travelers Vaccines Sales Market Share by End Users (2016-2027) Figure 76. Latin America Travelers Vaccines Revenue Market Share by End Users (2016-2027) Figure 77. Latin America Travelers Vaccines Sales Share by Country (2016-2027) Figure 78. Latin America Travelers Vaccines Revenue Share by Country (2016-2027) Figure 79. Mexico Travelers Vaccines Revenue (2016-2027) & (US$ Million) Figure 80. Brazil Travelers Vaccines Revenue (2016-2027) & (US$ Million) Figure 81. Argentina Travelers Vaccines Revenue (2016-2027) & (US$ Million) Figure 82. Middle East and Africa Travelers Vaccines Sales Market Share by Type (2016-2027) Figure 83. Middle East and Africa Travelers Vaccines Revenue Market Share by Type (2016-2027) Figure 84. Middle East and Africa Travelers Vaccines Sales Market Share by End Users (2016-2027) Figure 85. Middle East and Africa Travelers Vaccines Revenue Market Share by End Users (2016-2027) Figure 86. Middle East and Africa Travelers Vaccines Sales Share by Country (2016-2027) Figure 87. Middle East and Africa Travelers Vaccines Revenue Share by Country (2016-2027) Figure 88. Turkey Travelers Vaccines Revenue (2016-2027) & (US$ Million) Figure 89. Saudi Arabia Travelers Vaccines Revenue (2016-2027) & (US$ Million) Figure 90. U.A.E Travelers Vaccines Revenue (2016-2027) & (US$ Million) Figure 91. Travelers Vaccines Value Chain Figure 92. Travelers Vaccines Production Process Figure 93. Channels of Distribution Figure 94. Distributors Profiles Figure 95. Bottom-up and Top-down Approaches for This Report Figure 96. Data Triangulation Figure 97. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us